ELK4 and colorectal cancer: One study of colorectal cancer reported that LAMB3 overexpression was activated by BRD2/acetylated ELK4 complex; furthermore, LAMB3 overexpression activated AKT and resulted in degradation of FOXO3/4, a tumor suppressor protein [25].